← Back to patent-cliff list
罗红霉素/盐酸氨溴索
Tier C — Watch / tradeRoxithromycin/Ambroxol Hydrochloride
山东罗欣药业集团股份有限公司
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：50S ribosomal subunit
Indications (approved)：慢性支气管炎、支气管炎
Regional status
US
-
EU
-
China
批准上市
2010-01-15
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Roxithromycin/Ambroxol Hydrochloride?
Approved indications include: 慢性支气管炎, 支气管炎.
When does the Roxithromycin/Ambroxol Hydrochloride patent expire?
No public expiry year is available for Roxithromycin/Ambroxol Hydrochloride yet; this page updates once verified.
How do I get a quote for Roxithromycin/Ambroxol Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24